Company / R&D Expense
Erasca, Inc. R&D Expense History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$115.4M
FY2024
5-year range
$29.6M / $115.4M
FY2020-FY2024
Trend
+11.1%
vs FY2023
Sector context
#132 of 210
Health Care
What the data says
At $115M, Erasca, Inc.'s r&d expense ranks #132 of 210 in the Health Care sector. Improved from $112M to $115M over the past 2 years.
Based on SEC 10-K filings.
$115M in FY2024 with a 3-year CAGR of +16.0%.
Improved from $112M to $115M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +16.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#132 of 210 in Health CareTop 63% of 210This company $115.4M Sector average $644.0M
▼
-82.1% below sector average
Key checks
Key Insights
- 3-year CAGR of +16.0%, indicating consistent growth.
- In FY2024, r&d expense increased 11.1% year-over-year.
- Ranks #132 out of 210 companies in the Health Care sector.
- Lowest r&d expense in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $115.4M | +11.1% |
| FY2023 | $103.8M | -7.7% |
| FY2022 | $112.5M | +52.1% |
| FY2021 | $73.9M | +150.2% |
| FY2020 | $29.6M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026